annual cash & cash equivalents:
$281.97M-$153.93M(-35.31%)Summary
- As of today (September 9, 2025), BEAM annual cash & cash equivalents is $281.97 million, with the most recent change of -$153.93 million (-35.31%) on December 31, 2024.
- During the last 3 years, BEAM annual cash & cash equivalents has fallen by -$278.03 million (-49.65%).
- BEAM annual cash & cash equivalents is now -49.65% below its all-time high of $559.99 million, reached on December 31, 2021.
Performance
BEAM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.15B-$69.61M(-5.71%)Summary
- As of today (September 9, 2025), BEAM quarterly cash & cash equivalents is $1.15 billion, with the most recent change of -$69.61 million (-5.71%) on June 30, 2025.
- Over the past year, BEAM quarterly cash & cash equivalents has increased by +$142.17 million (+14.10%).
- BEAM quarterly cash & cash equivalents is now -5.91% below its all-time high of $1.22 billion, reached on March 31, 2022.
Performance
BEAM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BEAM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | +14.1% |
| 3 y3 years | -49.6% | -1.4% |
| 5 y5 years | +657.5% | +404.6% |
BEAM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.6% | +21.1% | -5.7% | +35.2% |
| 5 y | 5-year | -49.6% | +657.5% | -5.9% | +468.9% |
| alltime | all time | -49.6% | >+9999.0% | -5.9% | +1152.4% |
BEAM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.15B(-5.7%) |
| Mar 2025 | - | $1.22B(+43.4%) |
| Dec 2024 | $281.97M(-35.3%) | $850.74M(-8.1%) |
| Sep 2024 | - | $925.76M(-8.2%) |
| Jun 2024 | - | $1.01B(-7.9%) |
| Mar 2024 | - | $1.09B(-8.0%) |
| Dec 2023 | $435.89M(+87.3%) | $1.19B(+17.2%) |
| Sep 2023 | - | $1.02B(-5.4%) |
| Jun 2023 | - | $1.07B(+1.3%) |
| Mar 2023 | - | $1.06B(-1.7%) |
| Dec 2022 | $232.77M | $1.08B(-1.5%) |
| Sep 2022 | - | $1.09B(-6.1%) |
| Jun 2022 | - | $1.17B(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.22B(+26.6%) |
| Dec 2021 | $559.99M(+245.3%) | $965.65M(+3.5%) |
| Sep 2021 | - | $933.40M(+51.7%) |
| Jun 2021 | - | $615.28M(+22.2%) |
| Mar 2021 | - | $503.48M(+68.0%) |
| Dec 2020 | $162.17M(+335.7%) | $299.67M(+48.2%) |
| Sep 2020 | - | $202.22M(-11.3%) |
| Jun 2020 | - | $227.95M(-10.1%) |
| Mar 2020 | - | $253.44M(+175.9%) |
| Dec 2019 | $37.22M(-74.6%) | $91.85M(-17.2%) |
| Sep 2019 | - | $110.89M(-24.3%) |
| Dec 2018 | $146.44M(+7603.5%) | $146.44M |
| Dec 2017 | $1.90M | - |
FAQ
- What is Beam Therapeutics Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. annual cash & cash equivalents year-on-year change?
- What is Beam Therapeutics Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
What is Beam Therapeutics Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of BEAM is $281.97M
What is the all time high annual cash & cash equivalents for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high annual cash & cash equivalents is $559.99M
What is Beam Therapeutics Inc. annual cash & cash equivalents year-on-year change?
Over the past year, BEAM annual cash & cash equivalents has changed by -$153.93M (-35.31%)
What is Beam Therapeutics Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BEAM is $1.15B
What is the all time high quarterly cash & cash equivalents for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high quarterly cash & cash equivalents is $1.22B
What is Beam Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, BEAM quarterly cash & cash equivalents has changed by +$142.17M (+14.10%)